{"id":7851,"date":"2010-05-31T17:25:08","date_gmt":"2010-06-01T00:25:08","guid":{"rendered":"http:\/\/www.bradblog.com\/?p=7851"},"modified":"2010-06-01T10:41:49","modified_gmt":"2010-06-01T17:41:49","slug":"winograd-misses-debate-chance-to-slam-harmans-dissembling-conflicts-of-interest","status":"publish","type":"post","link":"https:\/\/bradblog.com\/?p=7851","title":{"rendered":"Winograd Misses &#8216;Debate&#8217; Chance to Slam Harman&#8217;s Dissembling, Conflicts-of-Interest"},"content":{"rendered":"<p><i>Guest blogged by Ernest A. Canning<\/i><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/BradBlog.com\/Images\/Harman_v_Winograd3.jpg\" hspace=\"6\" vspace=\"3\" border=\"0\" align=\"right\">No doubt, the last person eight-term &#8220;Blue Dog&#8221; Democrat Rep. Jane Harman (CA-36) expected to see when she sat down for a <a href=\"http:\/\/www.facebook.com\/notes\/marcy-winograd-for-congress\/winograd-debates-harman-at-ca-dem-convention-listen-to-audio\/10150170308240206\">Progressive Caucus panel discussion<\/a> on April 20 at the California Democratic Convention was the progressive Democratic challenger for her U.S. House seat, Marcy Winograd.  In fact, Winograd wasn&#8217;t even in the room when Harman began to speak.<\/p>\n<p>Winograd <a href=\"http:\/\/downwithtyranny.blogspot.com\/2010\/04\/jane-harmans-deception-blows-up-in-her.html\">explained<\/a>:<\/p>\n<div class=\"media\">I spoke, then left, then got a cell phone call: &#8220;Get back here. Jane Harman just arrived.&#8221; I ran back downstairs, returned to the crowded room, and quietly sat down, unbeknownst to Jane, just three bodies down from her on the panel. I waited for her to finish her thought, then jumped in.<\/div>\n<p>Winograd seized the moment to engage in a debate of sorts (<em>video below<\/em>), confronting the wealthy eight-term Congresswoman on a range of issues, including Harman&#8217;s committee vote to significantly extend Big Pharma&#8217;s patent protection over biomedical drugs.  Harman&#8217;s response was remarkably deceptive; yet, perhaps because this was not a pre-scheduled &#8220;debate,&#8221; Winograd failed to seize a rare face-to-face moment to directly confront Harman&#8217;s conflicts-of-interest and prevarication&#8230;<\/p>\n<p><!--more--><\/p>\n<p>There are a number of aspects of this confrontation worthy of note&#8211;especially Harman&#8217;s derision of the <a href=\"http:\/\/pdamerica.org\/\">Progressive Democrats of America&#8217;s<\/a> core value of &#8220;Health Care Not Warfare&#8221; in response to Winograd&#8217;s opening remark that while she agrees &#8220;fiscal responsibility is really important,&#8221;  Winograd does not see the expenditure of &#8220;nearly a trillion dollars on perpetual war and occupation&#8221; as &#8220;fiscally responsible.&#8221;  Harman played the fear card as she derisively said that &#8220;slogans don&#8217;t solve anything.&#8221;<\/p>\n<p>Now, perhaps some might think it uncouth, but that seemed like an ideal time to point out, as we did <a href=\"https:\/\/bradblog.com\/?p=7599\">previously<\/a>, that &#8220;Harman, whose committee assignments include Homeland Security and a subcommittee on Border, Maritime and Global Counterterrorism, invested $6,260,000 in military contracts.&#8221;<\/p>\n<p>Next, Winograd challenged Harman&#8217;s committee vote in favor of the &#8220;Eshoo amendment,&#8221; which we also <a href=\"https:\/\/bradblog.com\/?p=7599\">previously explained<\/a>: <\/p>\n<div class=\"media\">Rep. Anna G. Eshoo (D-CA) successfully inserted an amendment to the House health care &#8220;reform&#8221; bill which gives &#8220;developers of innovative biomedical drugs 12 years of statutory protection from generic competition, significantly extending their patent rights.&#8221; According to Michael Hiltzik of the <em>Los Angeles Times<\/em>, the Eshoo amendment would <a href=\"http:\/\/articles.latimes.com\/2009\/dec\/17\/business\/la-fi-hiltzik17-2009dec17\">provide<\/a> &#8220;a big payoff to biotech firms and their venture backers by hindering the entry of a new class of generic drugs into the market.&#8221; <\/p>\n<p>The Eshoo amendment succeeded after Harman joined with Eshoo in Committee to kill an amendment offered by Henry Waxman (D-CA) which would have provided &#8220;a 5-year fast-track of generic biologics&#8230;.A May 15, 2009 financial disclosure statement Harman filed with the House of Representatives reveals Harman&#8217;s 2008 investment portfolio included stock in at least three biologic manufacturers: Pfizer, Abbot Labs, and Johnson &#038; Johnson.&#8221;<\/p><\/div>\n<p>Harman first sought to evade Winograd&#8217;s direct challenge by stating that she would have liked to vote for a better health care bill and then saying that Senator Ted Kennedy (D-MA) had inserted it into the bill.  This produced a remarkable colloquy between Harman and fellow panelist <a href=\"http:\/\/en.wikipedia.org\/wiki\/Jane_Hamshe\">Jane Hamsher<\/a>:<\/p>\n<div class=\"media\">Hamsher:  We&#8217;re talking about a committee vote that you took.<\/p>\n<p>Harman:  Yes I did.  Ted Kennedy was the author of that amendment.  Ted Kennedy felt, and Ann Eshoo felt and I felt that biologics are very different from other forms of medicine.  They are not identical, and I wanted to be sure that the products we use to all the things that Marcy Winograd just said\u2026are safe and effective.  And that is why I made that vote.<\/p>\n<p>Hamsher:  So making them not available for 12 years in generic form makes them safer?<\/p>\n<p>Harman:  The argument is that makes them safer because it makes sure that they work.  Yes.<\/p>\n<p>Hamsher:  Nobody thought that.  Even the pharmaceutical companies weren&#8217;t saying that.<\/p>\n<p>Harman:  I don&#8217;t talk to Big Pharma.  They&#8217;re not supporters of mine.&#8221;<\/p><\/div>\n<p>Harman&#8217;s right!  She doesn&#8217;t need to &#8220;talk to Big Pharma.&#8221;  As one of the wealthiest members of Congress, with an investment portfolio that includes stock in three biologic manufactures, Harman <em>is<\/em> an integral part of Big Pharma just as she is an integral part of the military industrial complex.  Marcy Winograd, who was well aware of these ties, had missed a golden face-to-face opportunity to call Harman out not only for her conflict-of-interest but for her shameless dissembling. <\/p>\n<p>To her credit, however, Winograd subsequently issued a <a href=\"http:\/\/www.pdamerica.org\/articles\/campaigns\/2010-05-25-11-20-32-campaigns.php\">press release<\/a> in which she challenged Harman &#8220;to immediately divest of up to $8.3 million worth of investments in military contracting firms and return over $60,000 in campaign contributions from military contractors.&#8221;   <\/p>\n<p>The Democratic primary in California takes place on June 8th.<\/p>\n<p><center><strong>* * *<\/strong><\/center><\/p>\n<p><em>Marcy Winograd&#8217;s and Jane Harmon&#8217;s unintended debate during panel session of CA Progressive Caucus &#8230;<\/em><\/p>\n<p><center><object width=\"400\" height=\"385\"><param name=\"movie\" value=\"http:\/\/www.youtube.com\/v\/hwag4AwR1fE&#038;color1=0xb1b1b1&#038;color2=0xd0d0d0&#038;hl=en_US&#038;feature=player_embedded&#038;fs=1\"><\/param><param name=\"allowFullScreen\" value=\"true\"><\/param><param name=\"allowScriptAccess\" value=\"always\"><\/param><embed src=\"http:\/\/www.youtube.com\/v\/hwag4AwR1fE&#038;color1=0xb1b1b1&#038;color2=0xd0d0d0&#038;hl=en_US&#038;feature=player_embedded&#038;fs=1\" type=\"application\/x-shockwave-flash\" allowfullscreen=\"true\" allowScriptAccess=\"always\" width=\"400\" height=\"385\"><\/embed><\/object><\/center><\/p>\n<p><center><object width=\"400\" height=\"385\"><param name=\"movie\" value=\"http:\/\/www.youtube.com\/v\/E6hQp-DzKMM&#038;color1=0xb1b1b1&#038;color2=0xd0d0d0&#038;hl=en_US&#038;feature=player_embedded&#038;fs=1\"><\/param><param name=\"allowFullScreen\" value=\"true\"><\/param><param name=\"allowScriptAccess\" value=\"always\"><\/param><embed src=\"http:\/\/www.youtube.com\/v\/E6hQp-DzKMM&#038;color1=0xb1b1b1&#038;color2=0xd0d0d0&#038;hl=en_US&#038;feature=player_embedded&#038;fs=1\" type=\"application\/x-shockwave-flash\" allowfullscreen=\"true\" allowScriptAccess=\"always\" width=\"400\" height=\"385\"><\/embed><\/object><\/center><\/p>\n<p><center><strong>* * *<\/strong><\/center><\/p>\n<p><em>Ernest A. Canning has been an active member of the California state bar since 1977.  Mr. Canning has received both undergraduate and graduate degrees in political science as well as a juris doctor.  He is also a Vietnam vet (4th Infantry, Central Highlands 1968).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Guest blogged by Ernest A. Canning No doubt, the last person eight-term &#8220;Blue Dog&#8221; Democrat Rep. Jane Harman (CA-36) expected to see when she sat down for a Progressive Caucus panel discussion on April 20 at the California Democratic Convention was the progressive Democratic challenger for her U.S. House seat, Marcy Winograd. In fact, Winograd [&hellip;]<\/p>\n","protected":false},"author":107,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ep_exclude_from_search":false,"footnotes":""},"categories":[21,299,420,416,198],"tags":[],"coauthors":[],"class_list":["post-7851","post","type-post","status-publish","format-standard","hentry","category-california","category-democrats","category-election-2010","category-jane-harman","category-us-house","bb-type-bradblog"],"acf":[],"_links":{"self":[{"href":"https:\/\/bradblog.com\/index.php?rest_route=\/wp\/v2\/posts\/7851","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bradblog.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bradblog.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bradblog.com\/index.php?rest_route=\/wp\/v2\/users\/107"}],"replies":[{"embeddable":true,"href":"https:\/\/bradblog.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7851"}],"version-history":[{"count":0,"href":"https:\/\/bradblog.com\/index.php?rest_route=\/wp\/v2\/posts\/7851\/revisions"}],"wp:attachment":[{"href":"https:\/\/bradblog.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7851"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bradblog.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7851"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bradblog.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7851"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/bradblog.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcoauthors&post=7851"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}